Daron Evans is CEO & President at NEPHROS INC (NEPH). They have made 33 open-market trades across 4 companies since 2008, most recently 2026-07-02.
CIK 0001411726
33 open-market purchases totalling $893K since 2008, never a sale. Across 32 scored buys the stock is up 21.0% at ninety days, and 16.7 points ahead of the S&P over the same stretch.
32 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RZLT | 411,400 | $1.5M |
| NLTX | 10,200 | $142K |
| NEPH | 8,947 | $32K |
| NILT.OB | 200 | — |
| Total | $1.6M |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close. 1 holding could not be priced and is excluded from the total.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 69% | 53% | 53% |
| Avg Move | +6.8% | +10.3% | +21.0% |
| Alpha | -5.2% | +9.0% | +16.7% |
| Scored | 32 | 32 | 32 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RZLT | BUY | 2026-03-30 | 2026-03-31 | $2.85 | $29K | +14.2% | +1.3% | +61.4% |
| RZLT | BUY | 2025-12-15 | 2025-12-15 | $1.77 | $75K | +61.8% | +64.8% | +50.9% |
| RZLT | BUY | 2025-12-09 | 2024-12-10 | $— | — | -11.1% | -0.8% | -27.1% |
| RZLT | BUY | 2025-06-24 | 2025-06-24 | $4.05 | $20K | +16.6% | +37.5% | +90.6% |
| RZLT | BUY | 2025-03-26 | 2025-03-28 | $2.89 | $58K | -7.8% | +28.3% | +47.1% |
| RZLT | BUY | 2024-12-18 | 2024-12-18 | $4.29 | $43K | +16.7% | +16.0% | -19.8% |
| RZLT | BUY | 2024-12-12 | 2024-12-12 | $4.60 | $41K | -7.2% | +0.0% | -20.8% |
| RZLT | BUY | 2024-06-14 | 2024-06-14 | $4.04 | $162K | +0.8% | +21.9% | +31.2% |
| RZLT | BUY | 2024-05-29 | 2024-05-31 | $3.50 | $2K | +36.3% | +7.2% | +18.2% |
| RZLT | BUY | 2024-05-23 | 2024-05-28 | $3.22 | $10K | +55.4% | +9.0% | +27.7% |
| RZLT | BUY | 2024-03-15 | 2024-03-19 | $1.69 | $34K | +26.0% | +71.9% | +100.5% |
| RZLT | BUY | 2024-03-08 | 2024-03-08 | $1.93 | $97K | -4.0% | +27.1% | +180.9% |
| RZLT | BUY | 2024-02-16 | 2024-02-20 | $1.31 | $61K | +24.1% | +32.4% | +93.8% |
| NEPH | BUY | 2020-03-12 | 2020-03-12 | $6.65 | $17K | -6.5% | +16.7% | +20.5% |
| NEPH | BUY | 2020-03-05 | 2020-03-05 | $8.44 | $21K | -25.9% | -23.1% | -8.4% |
| NEPH | BUY | 2019-11-18 | 2019-11-18 | $8.35 | $8K | +3.1% | +6.3% | +9.6% |
| NEPH | BUY | 2019-08-22 | 2019-08-22 | $6.92 | $14K | -8.8% | +28.3% | +16.1% |
| NEPH | BUY | 2019-06-14 | 2019-06-14 | $0.60 | $47K | +3.0% | -1.8% | +11.3% |
| NEPH | BUY | 2018-04-10 | 2018-04-12 | $0.45 | $30K | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2017-09-05 | 2017-09-06 | $0.24 | $7K | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2017-08-22 | 2017-08-23 | $0.25 | $500 | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2017-08-11 | 2017-08-11 | $0.26 | $18K | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2017-06-09 | 2017-06-13 | $0.26 | $6K | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2017-05-18 | 2017-05-19 | $0.26 | $8K | +3.0% | -1.8% | -1.8% |
| NEPH | BUY | 2016-12-07 | 2016-12-09 | $0.32 | $1K | +3.0% | -1.8% | -1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.